News

Fierce Biotech52m
Endometrial cancer data on Genmab’s Elahere rival beat forecast, fuelling push into phase 3
Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endome | Genmab has shared the first data on ...